Clinical Trials Logo

Congenital Anomalies clinical trials

View clinical trials related to Congenital Anomalies.

Filter by:
  • None
  • Page 1

NCT ID: NCT05290701 Enrolling by invitation - Clinical trials for Genetic Diseases, Inborn

Evaluating Prenatal Exome Sequencing Study

EPES
Start date: February 21, 2022
Phase:
Study type: Observational

This study evaluates the impact of the various outcomes of pES (definitive diagnosis, probable diagnosis and IF) on clinical decision making and on parental psychological wellbeing, compared between different analysis strategies to investigate the clinical utility, defined as the balance between potential harms and benefits.

NCT ID: NCT04598503 Completed - Clinical trials for Congenital Anomalies

Congenital Anomalies and Risk Factors

Start date: December 1, 2017
Phase:
Study type: Observational [Patient Registry]

The aim of the study is to determine the prevalence, describe the types and risk factors of congenital anomalies among newborns admitted to Neonatal Intensive Care Unit (NICU) of Assiut University Children Hospital (AUCH). It is a prospective and a case control study was performed and screening of the newborn admitted at NICU of Assiut University Children Hospital during the period of 6 months from 1-12-2017 to the end of 5-2018 the sample was 346 newborns, 173 cases and 173 control. Data were collected using a record checklist and an interviewing questionnaire. Conclusion: The prevalence of congenital anomalies was 22.97%. The most common anomalies were gastrointestinal anomalies (GIT), musculoskeletal anomalies, multiple anomalies and circulatory system anomalies. The risk factors were consanguineous marriage, positive family history, urban areas, full-term and singleton pregnancies.

NCT ID: NCT03888794 Not yet recruiting - Clinical trials for Congenital Anomalies

MRI Versus Four Dimensional Ultrasound in Detection of CNS Fetal Congenital Anomalies

Start date: May 20, 2019
Phase:
Study type: Observational

Congenital central nervous system (CNS) anomalies are common and most devastating. They occur in frequency of about 1.4 to 1.6 per 1000 live births but are seen in about 3-6% of still births.They account for 40% of deaths of all infants in the first year of life. In survivors, they cause a variety of neurological disorders, mental retardation or drug resistant epilepsy. CNS anomalies are usually compatible with life, prolonged hospitalization, higher health care costs, uncertain future life quality and significant burden to families and society.

NCT ID: NCT02553148 Completed - Cancer Clinical Trials

Estimating the Global Need for Palliative Care for Children

Start date: June 2014
Phase: N/A
Study type: Observational

A cross-sectional analysis of prevalence data from a stratified sample of 23 countries used to estimate the global need for palliative care for children aged 0-19 years. Prevalence data, from the Institute for Health Metrics and Evaluation, was for 12 major diagnostic groups needing children's palliative care according to WHO and UNICEF guidelines.